Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Baxter Hlthcare Drug Patent Portfolio

Baxter Hlthcare owns 6 orange book drugs protected by 10 US patents with Extraneal having the least patent protection, holding only 2 patents. And Brevibloc In Plastic Container with maximum patent protection, holding 4 patents. Given below is the list of Baxter Hlthcare's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7635773 Sulfoalkyl ether cyclodextrin compositions 13 Mar, 2029
Active
US6869939 Formulations containing amiodarone and sulfoalkyl ether cyclodextrin 04 May, 2022 Expired
US6310094 Ready-to-use esmolol solution 12 Jul, 2021 Expired
US6528540 Esmolol formulation 12 Jul, 2021 Expired
US6310094 Ready-to-use esmolol solution 12 Jan, 2021 Expired
US6528540 Esmolol formulation 12 Jan, 2021 Expired
US6248726 Method of peritoneal dialysis using glucose polymer solutions 19 Jun, 2018 Expired
US6077836 Peritoneal dialysis and compositions for use therein 20 Jun, 2017 Expired
US5617906 Container for anaesthetic agent 08 Oct, 2014 Expired
US5617906 Container for anaesthetic agent 08 Apr, 2014 Expired


Given below is the list of recent legal activities going on the following drug patents of Baxter Hlthcare.

Activity Date Patent Number
Patent litigations
Correspondence Address Change
Critical
04 Dec, 2022 US7635773
Correspondence Address Change
Critical
04 Dec, 2022 US6869939
Payment of Maintenance Fee, 12th Year, Large Entity 09 Jun, 2021 US7635773
File Marked Found 07 Aug, 2018 US6310094
File Marked Found 07 Aug, 2018 US6310094
File Marked Found 07 Aug, 2018 US6310094
Entity Status Set To Undiscounted (Initial Default Setting or Status Change) 09 Jun, 2016 US6869939
Termination or Final Written Decision 27 Apr, 2016 US6528540
Termination or Final Written Decision 27 Apr, 2016 US6310094
Termination or Final Written Decision 27 Apr, 2016 US6528540
Termination or Final Written Decision 27 Apr, 2016 US6528540
Termination or Final Written Decision 27 Apr, 2016 US6310094
Termination or Final Written Decision 27 Apr, 2016 US6310094
Petition Requesting Trial 19 Nov, 2015 US6310094
Petition Requesting Trial 19 Nov, 2015 US6528540


Baxter Hlthcare's Drug Patent Litigations

Baxter Hlthcare's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Jan 01, 1, against patent number US6077836. The petitioner , challenged the validity of this patent, with MILNER as the respondent. Click below to track the latest information on how companies are challenging Baxter Hlthcare's patents.

Patent Proceeding Filing Date Status Respondent Petitioner
Patent litigations
US6310094 November, 2015 Terminated-Denied
(27 Apr, 2016)
Baxter International Inc. Mylan Pharmaceuticals Inc.
US6528540 November, 2015 Terminated-Denied
(27 Apr, 2016)
Baxter International Inc. Mylan Pharmaceuticals Inc.
US6248726 May, 1995 Decision
(28 Aug, 2000)
ALSOP et al
US6077836 January, 1 Decision
(14 Sep, 1999)
MILNER


Baxter Hlthcare's Family Patents

Baxter Hlthcare drugs have patent protection in a total of 20 countries. It's US patent count contributes only to 21.2% of its total global patent coverage. 5 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Baxter Hlthcare Drug List

Given below is the complete list of Baxter Hlthcare's drugs and the patents protecting them.


1. Brevibloc

Brevibloc is protected by 4 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6310094
(Pediatric)
Ready-to-use esmolol solution 12 Jul, 2021
(3 years ago)
Expired
US6528540
(Pediatric)
Esmolol formulation 12 Jul, 2021
(3 years ago)
Expired
US6310094 Ready-to-use esmolol solution 12 Jan, 2021
(3 years ago)
Expired
US6528540 Esmolol formulation 12 Jan, 2021
(3 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Brevibloc's drug page


2. Brevibloc Double Strength In Plastic Container

Brevibloc Double Strength In Plastic Container is protected by 4 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6310094
(Pediatric)
Ready-to-use esmolol solution 12 Jul, 2021
(3 years ago)
Expired
US6528540
(Pediatric)
Esmolol formulation 12 Jul, 2021
(3 years ago)
Expired
US6310094 Ready-to-use esmolol solution 12 Jan, 2021
(3 years ago)
Expired
US6528540 Esmolol formulation 12 Jan, 2021
(3 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Brevibloc Double Strength In Plastic Container's drug page


3. Brevibloc In Plastic Container

Brevibloc In Plastic Container is protected by 4 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6310094
(Pediatric)
Ready-to-use esmolol solution 12 Jul, 2021
(3 years ago)
Expired
US6528540
(Pediatric)
Esmolol formulation 12 Jul, 2021
(3 years ago)
Expired
US6310094 Ready-to-use esmolol solution 12 Jan, 2021
(3 years ago)
Expired
US6528540 Esmolol formulation 12 Jan, 2021
(3 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Brevibloc In Plastic Container's drug page


4. Extraneal

Extraneal is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6248726 Method of peritoneal dialysis using glucose polymer solutions 19 Jun, 2018
(6 years ago)
Expired
US6077836 Peritoneal dialysis and compositions for use therein 20 Jun, 2017
(7 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Extraneal's drug page


5. Nexterone

Nexterone is protected by 2 patents, out of which 1 has expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7635773 Sulfoalkyl ether cyclodextrin compositions 13 Mar, 2029
(4 years from now)
Active
US6869939 Formulations containing amiodarone and sulfoalkyl ether cyclodextrin 04 May, 2022
(2 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Nexterone's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

6. Suprane

Suprane is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5617906
(Pediatric)
Container for anaesthetic agent 08 Oct, 2014
(10 years ago)
Expired
US5617906 Container for anaesthetic agent 08 Apr, 2014
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Suprane's drug page